|
|
||||||||
Ann Thorac Surg 1997;64:216-219
© 1997 The Society of Thoracic Surgeons
Thoracic Oncology Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York
Accepted for publication January 27, 1997.
| Abstract |
|---|
|
|
|---|
Methods. Methylcholanthrene-induced sarcoma cell suspensions were introduced into lung parenchyma of Fischer rats via limited thoracotomy and lung puncture, or instilled into a distal airway after tracheal puncture and catheterization. Intrapulmonary tumor location, implantation mortality, procedure length, and animal survival were recorded.
Results. Single pulmonary nodules developed at the implanted position in 100% (n = 320) and 95% (62/65) of animals after direct injection into the pulmonary parenchyma or via tracheal puncture and instillation. Operative mortality was 2% and 5% via lung or tracheal implantation, respectively. Less than 5 minutes was required for each implantation. Mean survival time was 24 ± 2 and 26 ± 6 days after lung or tracheal implantation in animals allowed to survive until tumor-induced death.
Conclusions. These easily performed, reproducible methods of establishing solitary intrapulmonary tumors are useful tools for lung cancer research.
| Introduction |
|---|
|
|
|---|
We describe two readily performed methods for intrapulmonary tumor development that yield reproducible, accurately placed, solitary pulmonary nodules with low implantation mortality. These methods are easily learned. The open lung puncture method requires intubation and ventilation, whereas the tracheal puncture method necessitates only sedation and anesthesia. A solitary pulmonary nodule model approximates clinical lung cancer and therefore provides a useful tool for lung cancer research.
| Material and Methods |
|---|
|
|
|---|
The tumor cell line is a methylcholanthrene-induced rat sarcoma (MCA) that has been serially passed subcutaneously over many years in our laboratory. It has been extensively characterized and shown to be locally invasive and to rarely metastasize [6, 7].
Cell Suspension Preparation
Implanted tumor cells were derived after collagenase digestion of tumor tissue or cell culture. To create a cell suspension from tumor tissue, we excised approximately 5 g of fresh tumor from the flanks of passage animals and minced it into 1-mm3pieces. One percent collagenase D (Boehringer Mannheim, Indianapolis, IN) in phosphate-buffered saline solution was added to the tumor. The solution was heated in a shaking water bath for 40 minutes at 37°C. The suspension was then filtered through a 60-µm metal mesh and centrifuged at 1,000 gfor 5 minutes. The supernatant was removed and the pellet was washed two times with phosphate-buffered saline solution. The washed pellet was resuspended in cold Roswell Park Memorial Institute medium + 5% fetal bovine serum to a concentration of 3 x 107 cells/mL. Tumor cell suspension viability was 100% as assessed by the trypan blue exclusion test.
Tumor Implantation by Thoracotomy and Lung Puncture
Animals were anesthetized with pentobarbital, 50 mg/kg, intraperitoneally. Under direct visualization the animals were intubated with a 16-gauge intravenous catheter placed over a guidewire and then placed on a volume ventilator (Rodent Ventilator model 683; Harvard Apparatus, South Natick, MA) [8]. Ventilation was maintained at a tidal volume of 10 mL/kg, with 100% O2at a rate of 75 breaths/min. The left chest was shaved, prepared with a 10% povidone-iodine solution, and entered through the seventh intercostal space. The skin incision was 1 cm in length. The unilobar left lung was retracted from the thoracic cavity. A 27-gauge needle attached to a 0.5-mL insulin syringe was inserted into the lung to a depth of 0.5 cm. Tumor cells (1.5 x 106) in a 50 µL volume of Roswell Park Memorial Institute medium were injected into the lung parenchyma (Fig 1
). A cotton-tipped applicator was pressed on the site of puncture as the needle was withdrawn to prevent the tumor suspension from leaking out of the lung as well as to stop any bleeding caused by the puncture. To facilitate lung reexpansion a 16-gauge catheter connected to a 5-mL syringe was introduced into the left chest cavity to act as a chest tube system. The thoracotomy incision was closed. Negative pressure in the chest was created by traction on the syringe piston. When the animals were breathing spontaneously, their chest and endotracheal tubes were removed and animals were returned to their cages.
|
|
| Results |
|---|
|
|
|---|
Of the animals in which tumors were implanted for this descriptive article, mean survival time was 24 days (range, 20 to 32 days) after open lung implantation and 26 days (range, 9 to 40 days) after tracheal instillation (Fig 3
). Animals died of respiratory failure due to overwhelming pulmonary tumor burden. Body weights were not different between the two groups in the week after tumor implantation (Fig 4
). Tumor sizes were approximately 3.8 x 1.8 and 5.4 x 2.5 mm via lung implantation and 1.9 x 1.3 and 2.5 x 1.6 mm via trachea implantation on day 7 or day 10 after tumor implantation. Tumor sizes were measured on the samples fixed in 10% buffered formalin acetate (Fig 5
).
|
|
|
| Comment |
|---|
|
|
|---|
Potential difficulties with the open lung method are the requirement of endotracheal intubation and the development of thoracic adhesions possibly complicating experiments requiring repeat thoracotomy. We found intubation easy to master, and adhesions encountered at reoperation could be taken down with gentle traction on a cotton-tipped swab.
Intubation and thoracotomy are not required for the tracheal puncture and instillation method. Initial difficulty with this method involved the animals' inability to tolerate a large-volume tumor suspension instillation. Animals tolerated the 50-µL volume without difficulty.
The ability to dictate the intrapulmonary placement of tumor can be used to great advantage by the investigator. Localization is specific as to position in a lobe. Studies in our laboratory require mobilization of the hilar pulmonary vessels, and this region can be consistently spared from tumor involvement with both the pulmonary injection and tracheal instillation methods. Tumors can be visualized by the naked eye in approximately 5 days. Unexpected growth into the mediastinum and chest wall was not seen.
Previously we attempted to create solitary pulmonary nodules via percutaneous tumor cell suspension injection. Using percutaneous injection we encountered significant spillage of tumor suspension into the thoracic cavity, which led to extrapulmonary tumor growth. As our laboratory's studies necessitated tumors to be isolated to the lung, we developed the methods described in this article.
Many histologic tumor types can be used with our methods. Tumor development times would vary by line, but personal experience reveals our methods are not limited to MCA sarcoma. It is probable that other species of rat would tolerate either method of tumor development. We hope these methods will facilitate the investigation into the biologic basis for and the treatment of lung cancer.
| Footnotes |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. Onn, T. Isobe, S. Itasaka, W. Wu, M. S. O'Reilly, W. Ki Hong, I. J. Fidler, and R. S. Herbst Development of an Orthotopic Model to Study the Biology and Therapy of Primary Human Lung Cancer in Nude Mice Clin. Cancer Res., November 15, 2003; 9(15): 5532 - 5539. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Schneider, S. Kampfer, C. Loddenkemper, T. Foitzik, and H. J. Buhr Chemoembolization of the Lung Improves Tumor Control in a Rat Model Clin. Cancer Res., July 1, 2002; 8(7): 2463 - 2468. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ishikura, K. Kondo, T. Miyoshi, H. Kinoshita, Y. Takahashi, H. Fujino, and Y. Monden Suppression of Mediastinal Metastasis by Uracil-Tegafur or cis-Diamminedichloroplatinum(II) Using a Lymphogenous Metastatic Model in a Human Lung Cancer Cell Line Clin. Cancer Res., December 1, 2001; 7(12): 4202 - 4208. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ishikura, K. Kondo, T. Miyoshi, H. Kinoshita, T. Hirose, and Y. Monden Artificial lymphogenous metastatic model using orthotopic implantation of human lung cancer Ann. Thorac. Surg., June 1, 2000; 69(6): 1691 - 1695. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |